Spotlighting Lessons Learned from Validating & Implementing Organoids to De-Risk Oncology Therapeutic Development
Time: 11:30 am
day: Day 2
Details:
- Discussing the need to build robust protocols to enhance model reproducibility and empower their validation
- Employing techniques to characterize organoid and ensure reproducibility and translatability for safety studies
- Assessing the applications of organoids for safety considerations to de-risk therapeutic candidates before moving to patients
